nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.143	0.195	CbGbCtD
Pentobarbital—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.143	0.195	CbGbCtD
Pentobarbital—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.109	0.147	CbGbCtD
Pentobarbital—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0638	0.0865	CbGbCtD
Pentobarbital—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0593	0.0805	CbGbCtD
Pentobarbital—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0593	0.0805	CbGbCtD
Pentobarbital—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0378	0.0513	CbGbCtD
Pentobarbital—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0256	0.0347	CbGbCtD
Pentobarbital—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0249	0.0338	CbGbCtD
Pentobarbital—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0244	0.0331	CbGbCtD
Pentobarbital—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0217	0.0295	CbGbCtD
Pentobarbital—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0128	0.0173	CbGbCtD
Pentobarbital—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.012	0.0163	CbGbCtD
Pentobarbital—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00266	0.024	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00231	0.0209	CcSEcCtD
Pentobarbital—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00224	0.0202	CcSEcCtD
Pentobarbital—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.0188	CcSEcCtD
Pentobarbital—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00195	0.0176	CcSEcCtD
Pentobarbital—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00193	0.0174	CcSEcCtD
Pentobarbital—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00191	0.0173	CcSEcCtD
Pentobarbital—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.017	CcSEcCtD
Pentobarbital—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.0162	CcSEcCtD
Pentobarbital—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00167	0.0151	CcSEcCtD
Pentobarbital—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.0133	CcSEcCtD
Pentobarbital—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.0124	CcSEcCtD
Pentobarbital—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.012	CcSEcCtD
Pentobarbital—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.0116	CcSEcCtD
Pentobarbital—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00128	0.0115	CcSEcCtD
Pentobarbital—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.0109	CcSEcCtD
Pentobarbital—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.0107	CcSEcCtD
Pentobarbital—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.0102	CcSEcCtD
Pentobarbital—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00112	0.0101	CcSEcCtD
Pentobarbital—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.0101	CcSEcCtD
Pentobarbital—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.01	CcSEcCtD
Pentobarbital—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00983	CcSEcCtD
Pentobarbital—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00959	CcSEcCtD
Pentobarbital—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00952	CcSEcCtD
Pentobarbital—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00923	CcSEcCtD
Pentobarbital—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00915	CcSEcCtD
Pentobarbital—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00914	CcSEcCtD
Pentobarbital—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00909	CcSEcCtD
Pentobarbital—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.001	0.00904	CcSEcCtD
Pentobarbital—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000995	0.00898	CcSEcCtD
Pentobarbital—Tension—Formoterol—chronic obstructive pulmonary disease	0.000981	0.00885	CcSEcCtD
Pentobarbital—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000981	0.00885	CcSEcCtD
Pentobarbital—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000971	0.00876	CcSEcCtD
Pentobarbital—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000971	0.00876	CcSEcCtD
Pentobarbital—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000955	0.00862	CcSEcCtD
Pentobarbital—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000927	0.00836	CcSEcCtD
Pentobarbital—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000919	0.00829	CcSEcCtD
Pentobarbital—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000919	0.00829	CcSEcCtD
Pentobarbital—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000917	0.00827	CcSEcCtD
Pentobarbital—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000914	0.00824	CcSEcCtD
Pentobarbital—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000914	0.00824	CcSEcCtD
Pentobarbital—Agitation—Montelukast—chronic obstructive pulmonary disease	0.0009	0.00812	CcSEcCtD
Pentobarbital—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000895	0.00808	CcSEcCtD
Pentobarbital—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000868	0.00783	CcSEcCtD
Pentobarbital—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000865	0.0078	CcSEcCtD
Pentobarbital—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000863	0.00778	CcSEcCtD
Pentobarbital—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000848	0.00766	CcSEcCtD
Pentobarbital—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000848	0.00766	CcSEcCtD
Pentobarbital—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000848	0.00765	CcSEcCtD
Pentobarbital—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000847	0.00764	CcSEcCtD
Pentobarbital—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000831	0.0075	CcSEcCtD
Pentobarbital—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00083	0.00749	CcSEcCtD
Pentobarbital—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000801	0.00723	CcSEcCtD
Pentobarbital—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00079	0.00713	CcSEcCtD
Pentobarbital—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000785	0.00708	CcSEcCtD
Pentobarbital—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000763	0.00688	CcSEcCtD
Pentobarbital—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000763	0.00688	CcSEcCtD
Pentobarbital—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000758	0.00684	CcSEcCtD
Pentobarbital—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.00672	CcSEcCtD
Pentobarbital—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000726	0.00655	CcSEcCtD
Pentobarbital—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000726	0.00655	CcSEcCtD
Pentobarbital—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00072	0.0065	CcSEcCtD
Pentobarbital—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000711	0.00641	CcSEcCtD
Pentobarbital—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000709	0.0064	CcSEcCtD
Pentobarbital—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000698	0.0063	CcSEcCtD
Pentobarbital—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000698	0.0063	CcSEcCtD
Pentobarbital—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00618	CcSEcCtD
Pentobarbital—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000682	0.00615	CcSEcCtD
Pentobarbital—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000676	0.0061	CcSEcCtD
Pentobarbital—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000676	0.0061	CcSEcCtD
Pentobarbital—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000673	0.00607	CcSEcCtD
Pentobarbital—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000673	0.00607	CcSEcCtD
Pentobarbital—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000672	0.00606	CcSEcCtD
Pentobarbital—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000669	0.00603	CcSEcCtD
Pentobarbital—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000659	0.00595	CcSEcCtD
Pentobarbital—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000645	0.00582	CcSEcCtD
Pentobarbital—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000645	0.00582	CcSEcCtD
Pentobarbital—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000643	0.0058	CcSEcCtD
Pentobarbital—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000638	0.00575	CcSEcCtD
Pentobarbital—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000637	0.00575	CcSEcCtD
Pentobarbital—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000637	0.00575	CcSEcCtD
Pentobarbital—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000635	0.00573	CcSEcCtD
Pentobarbital—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000634	0.00572	CcSEcCtD
Pentobarbital—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000633	0.00571	CcSEcCtD
Pentobarbital—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000632	0.0057	CcSEcCtD
Pentobarbital—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.0055	CcSEcCtD
Pentobarbital—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00543	CcSEcCtD
Pentobarbital—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00543	CcSEcCtD
Pentobarbital—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000601	0.00542	CcSEcCtD
Pentobarbital—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000589	0.00531	CcSEcCtD
Pentobarbital—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00512	CcSEcCtD
Pentobarbital—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00054	0.00487	CcSEcCtD
Pentobarbital—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00054	0.00487	CcSEcCtD
Pentobarbital—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000529	0.00477	CcSEcCtD
Pentobarbital—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000519	0.00468	CcSEcCtD
Pentobarbital—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.00468	CcSEcCtD
Pentobarbital—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.00464	CcSEcCtD
Pentobarbital—Rash—Formoterol—chronic obstructive pulmonary disease	0.000515	0.00464	CcSEcCtD
Pentobarbital—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000514	0.00464	CcSEcCtD
Pentobarbital—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000514	0.00464	CcSEcCtD
Pentobarbital—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000511	0.00461	CcSEcCtD
Pentobarbital—Headache—Formoterol—chronic obstructive pulmonary disease	0.000511	0.00461	CcSEcCtD
Pentobarbital—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00051	0.0046	CcSEcCtD
Pentobarbital—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000508	0.00459	CcSEcCtD
Pentobarbital—Rash—Montelukast—chronic obstructive pulmonary disease	0.000504	0.00455	CcSEcCtD
Pentobarbital—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000504	0.00454	CcSEcCtD
Pentobarbital—Headache—Montelukast—chronic obstructive pulmonary disease	0.000501	0.00452	CcSEcCtD
Pentobarbital—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000495	0.00446	CcSEcCtD
Pentobarbital—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00442	CcSEcCtD
Pentobarbital—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00438	CcSEcCtD
Pentobarbital—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000486	0.00438	CcSEcCtD
Pentobarbital—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00438	CcSEcCtD
Pentobarbital—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.00437	CcSEcCtD
Pentobarbital—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000485	0.00437	CcSEcCtD
Pentobarbital—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00436	CcSEcCtD
Pentobarbital—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000476	0.00429	CcSEcCtD
Pentobarbital—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00428	CcSEcCtD
Pentobarbital—Secobarbital—CYP1A2—chronic obstructive pulmonary disease	0.00047	0.41	CrCbGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000465	0.00308	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000463	0.00307	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000463	0.00306	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000463	0.00306	CbGpPWpGaD
Pentobarbital—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00046	0.00415	CcSEcCtD
Pentobarbital—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00413	CcSEcCtD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000455	0.00301	CbGpPWpGaD
Pentobarbital—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00045	0.00406	CcSEcCtD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000447	0.00296	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000444	0.00294	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000436	0.00289	CbGpPWpGaD
Pentobarbital—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.00392	CcSEcCtD
Pentobarbital—CHRNA7—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000435	0.00288	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00043	0.00285	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000425	0.00281	CbGpPWpGaD
Pentobarbital—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000421	0.00279	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000419	0.00278	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000397	0.00263	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000392	0.00259	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00039	0.00258	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000389	0.00257	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000388	0.00257	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000381	0.00252	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000379	0.00251	CbGpPWpGaD
Pentobarbital—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000378	0.0025	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000377	0.0025	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000377	0.0025	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000375	0.00249	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000371	0.00245	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000371	0.00245	CbGpPWpGaD
Pentobarbital—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00037	0.00245	CbGpPWpGaD
Pentobarbital—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000366	0.00242	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000365	0.00242	CbGpPWpGaD
Pentobarbital—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000364	0.00329	CcSEcCtD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000364	0.00241	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000362	0.0024	CbGpPWpGaD
Pentobarbital—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000362	0.00326	CcSEcCtD
Pentobarbital—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00036	0.00324	CcSEcCtD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000358	0.00237	CbGpPWpGaD
Pentobarbital—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000356	0.00235	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000355	0.00235	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000354	0.00235	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000354	0.00235	CbGpPWpGaD
Pentobarbital—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000353	0.00318	CcSEcCtD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000348	0.0023	CbGpPWpGaD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000347	0.00229	CbGpPWpGaD
Pentobarbital—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000346	0.00312	CcSEcCtD
Pentobarbital—Phenobarbital—CYP1A1—chronic obstructive pulmonary disease	0.000344	0.3	CrCbGaD
Pentobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000342	0.00226	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000342	0.00226	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000342	0.00226	CbGpPWpGaD
Pentobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.00034	0.00225	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000339	0.00225	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000336	0.00222	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000335	0.00222	CbGpPWpGaD
Pentobarbital—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000334	0.00301	CcSEcCtD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000334	0.00221	CbGpPWpGaD
Pentobarbital—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000333	0.0022	CbGpPWpGaD
Pentobarbital—Phenobarbital—CYP1A2—chronic obstructive pulmonary disease	0.000332	0.289	CrCbGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00033	0.00219	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000329	0.00218	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000328	0.00217	CbGpPWpGaD
Pentobarbital—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.00294	CcSEcCtD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000323	0.00214	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000323	0.00214	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000319	0.00211	CbGpPWpGaD
Pentobarbital—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000319	0.00211	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000318	0.00211	CbGpPWpGaD
Pentobarbital—Shock—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00285	CcSEcCtD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000316	0.00209	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000311	0.00206	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000311	0.00206	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00031	0.00205	CbGpPWpGaD
Pentobarbital—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000306	0.00203	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000304	0.00201	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000302	0.002	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.0003	0.00199	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000298	0.00197	CbGpPWpGaD
Pentobarbital—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000294	0.00195	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000294	0.00194	CbGpPWpGaD
Pentobarbital—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000293	0.00194	CbGpPWpGaD
Pentobarbital—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.00264	CcSEcCtD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000292	0.00193	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000291	0.00193	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000289	0.00191	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000288	0.00191	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000286	0.0019	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000284	0.00188	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000283	0.00188	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000281	0.00186	CbGpPWpGaD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000281	0.00186	CbGpPWpGaD
Pentobarbital—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.00251	CcSEcCtD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000279	0.00184	CbGpPWpGaD
Pentobarbital—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.00251	CcSEcCtD
Pentobarbital—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.0025	CcSEcCtD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000276	0.00183	CbGpPWpGaD
Pentobarbital—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00248	CcSEcCtD
Pentobarbital—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000275	0.00182	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000274	0.00182	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000274	0.00181	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000272	0.0018	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000271	0.00179	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000267	0.00177	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000267	0.00177	CbGpPWpGaD
Pentobarbital—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000266	0.00176	CbGpPWpGaD
Pentobarbital—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00239	CcSEcCtD
Pentobarbital—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00237	CcSEcCtD
Pentobarbital—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000262	0.00173	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000257	0.0017	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000257	0.0017	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000256	0.00169	CbGpPWpGaD
Pentobarbital—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000255	0.00169	CbGpPWpGaD
Pentobarbital—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00229	CcSEcCtD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000252	0.00167	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000251	0.00166	CbGpPWpGaD
Pentobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.00165	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000248	0.00164	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000245	0.00162	CbGpPWpGaD
Pentobarbital—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000244	0.00162	CbGpPWpGaD
Pentobarbital—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000242	0.0016	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000242	0.0016	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000237	0.00157	CbGpPWpGaD
Pentobarbital—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00214	CcSEcCtD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000235	0.00155	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000233	0.00155	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000224	0.00148	CbGpPWpGaD
Pentobarbital—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000222	0.00147	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000221	0.00147	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000219	0.00145	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000217	0.00144	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000216	0.00143	CbGpPWpGaD
Pentobarbital—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000214	0.00142	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000213	0.00141	CbGpPWpGaD
Pentobarbital—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00192	CcSEcCtD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000212	0.0014	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000211	0.0014	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00021	0.00139	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00021	0.00139	CbGpPWpGaD
Pentobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000209	0.00138	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000208	0.00138	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000205	0.00136	CbGpPWpGaD
Pentobarbital—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00184	CcSEcCtD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000204	0.00135	CbGpPWpGaD
Pentobarbital—Rash—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00183	CcSEcCtD
Pentobarbital—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000202	0.00134	CbGpPWpGaD
Pentobarbital—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00183	CcSEcCtD
Pentobarbital—Headache—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00182	CcSEcCtD
Pentobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.0002	0.00133	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000192	0.00127	CbGpPWpGaD
Pentobarbital—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00172	CcSEcCtD
Pentobarbital—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000188	0.00125	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00018	0.00119	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000179	0.00118	CbGpPWpGaD
Pentobarbital—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.00118	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000177	0.00118	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000171	0.00113	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000159	0.00105	CbGpPWpGaD
Pentobarbital—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.00104	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.00102	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000152	0.00101	CbGpPWpGaD
Pentobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.001	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.000988	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000147	0.000972	CbGpPWpGaD
Pentobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000144	0.000952	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000142	0.00094	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00014	0.000927	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.00013	0.000863	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00013	0.000861	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00013	0.00086	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00013	0.000858	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000129	0.000855	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.000841	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00083	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000124	0.000824	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.000824	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000124	0.000823	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000114	0.000757	CbGpPWpGaD
Pentobarbital—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.000756	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000111	0.000733	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000109	0.000725	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.000718	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000108	0.000717	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000105	0.000697	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.000682	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.23e-05	0.000611	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.11e-05	0.000603	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.1e-05	0.000602	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	9.02e-05	0.000597	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.97e-05	0.000594	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	8.93e-05	0.000591	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	8.72e-05	0.000578	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	8.02e-05	0.000531	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	7.7e-05	0.00051	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.7e-05	0.00051	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.59e-05	0.000503	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.48e-05	0.000496	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.48e-05	0.000496	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.37e-05	0.000488	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.28e-05	0.000482	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.27e-05	0.000482	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.97e-05	0.000462	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.88e-05	0.000455	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.65e-05	0.00044	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.61e-05	0.000438	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.58e-05	0.000436	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.52e-05	0.000432	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.52e-05	0.000431	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.51e-05	0.000431	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.46e-05	0.000428	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.35e-05	0.00042	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.24e-05	0.000413	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.2e-05	0.00041	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.08e-05	0.000403	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.78e-05	0.000383	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	5.62e-05	0.000372	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.58e-05	0.00037	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.47e-05	0.000362	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.4e-05	0.000357	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.32e-05	0.000352	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.32e-05	0.000352	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.31e-05	0.000352	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.23e-05	0.000346	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.56e-05	0.000302	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.51e-05	0.000298	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.5e-05	0.000298	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.42e-05	0.000293	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.37e-05	0.000289	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.19e-05	0.000278	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.14e-05	0.000274	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.99e-05	0.000264	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.98e-05	0.000263	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.92e-05	0.00026	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.88e-05	0.000257	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.81e-05	0.000252	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.79e-05	0.000251	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.74e-05	0.000248	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.72e-05	0.000246	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.65e-05	0.000242	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.52e-05	0.000233	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.49e-05	0.000231	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.43e-05	0.000227	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.2e-05	0.000212	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.19e-05	0.000211	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.19e-05	0.000211	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.07e-05	0.000203	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	3.04e-05	0.000201	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.77e-05	0.000183	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.55e-05	0.000169	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.54e-05	0.000168	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.13e-05	0.000141	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.12e-05	0.00014	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.1e-05	0.000139	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.06e-05	0.000136	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.96e-05	0.00013	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.92e-05	0.000127	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.87e-05	0.000124	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.85e-05	0.000123	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.85e-05	0.000123	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.73e-05	0.000114	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.69e-05	0.000112	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.56e-05	0.000103	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.3e-05	8.59e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.28e-05	8.48e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.26e-05	8.35e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.21e-05	7.98e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.19e-05	7.9e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.13e-05	7.49e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.13e-05	7.46e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	7.37e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	6.72e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.36e-06	6.2e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.8e-06	5.17e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.7e-06	5.1e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	7.68e-06	5.09e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	7.35e-06	4.87e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.17e-06	4.75e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.8e-06	4.5e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.62e-06	3.06e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.42e-06	2.93e-05	CbGpPWpGaD
